Authors' reply.
作者信息
Makwana Jalpa, Paranjape Saloni, Goswami Jyotsna
机构信息
Department of Anaesthesia, Jaslok Hospital and Research Centre, Mumbai, Maharashtra, India.
出版信息
Indian J Anaesth. 2011 May;55(3):310-1.
Abstract
摘要
相似文献
1
Authors' reply.作者回复。
Indian J Anaesth. 2011 May;55(3):310-1.
2
Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.红外斩波副镜的像差：作者对评论2的回复以及对评论1回复的延续
Appl Opt. 1985 Apr 1;24(7):944. doi: 10.1364/AO.24.000944.
3
Authors' reply: Comment on authors' reply: Patients' perception of risk: informed choice in prenatal testing for foetal aneuploidy.作者回复：对作者回复的评论：患者对风险的认知：胎儿非整倍体产前检测中的知情选择。
Singapore Med J. 2013 Apr;54(4):238. doi: 10.11622/smedj.2013084.
4
Authors' Reply.作者回复。
J Mol Diagn. 2018 Mar;20(2):266. doi: 10.1016/j.jmoldx.2017.12.001.
5
Authors' Reply.作者回复。
J Mol Diagn. 2018 Jan;20(1):125-126. doi: 10.1016/j.jmoldx.2017.11.002.
6
Authors' Reply: In reply.作者回复：作为回复。
J Trauma Acute Care Surg. 2020 Dec;89(6):e191. doi: 10.1097/TA.0000000000002926.
7
Reply to Senefeld and Hunter: Physiology in Medicine: Neuromuscular consequences of diabetic neuropathy. The authors' reply.对塞内费尔德和亨特的回复：医学中的生理学：糖尿病性神经病变的神经肌肉后果。作者的回复。
J Appl Physiol (1985). 2016 Jul 1;121(1):361. doi: 10.1152/japplphysiol.00423.2016.
8
Reply to: Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study".回复：对作者对关于“用于预防心脏性猝死的可穿戴式心脏复律除颤器：一项卫生技术评估和患者焦点小组研究”的批判性评价的回复的评论
Med Devices (Auckl). 2019 Mar 22;12:129-131. doi: 10.2147/MDER.S202581. eCollection 2019.
9
Authors' Reply to the Letter to the Editor: Reply to "Cognitive performance in women with fibromyalgia' by de Heredia-Torres and colleagues".作者对致编辑信的回复：对德埃雷迪亚 - 托雷斯及其同事所著《纤维肌痛女性的认知表现》的回复
Aust Occup Ther J. 2017 Aug;64(4):E101. doi: 10.1111/1440-1630.12385.
10
Authors' Reply.作者回复。
Am J Pathol. 2016 Aug;186(8):2234-2235. doi: 10.1016/j.ajpath.2016.06.001. Epub 2016 Jul 20.
本文引用的文献
1
Use of recombinant factor VIIa in orthotopic liver transplant.重组凝血因子VIIa在原位肝移植中的应用。
Indian J Anaesth. 2011 May;55(3):309-10. doi: 10.4103/0019-5049.82651.
2
Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting.重组因子 VIIa：对其在标签外使用的疗效和安全性证据的评估。
Hematology Am Soc Hematol Educ Program. 2010;2010:153-9. doi: 10.1182/asheducation-2010.1.153.
3
Antifibrinolytics in liver surgery.肝脏手术中的抗纤溶药物
Indian J Anaesth. 2010 Nov;54(6):489-95. doi: 10.4103/0019-5049.72636.
4
Safety of recombinant activated factor VII in randomized clinical trials.重组活化因子 VII 在随机临床试验中的安全性。
N Engl J Med. 2010 Nov 4;363(19):1791-800. doi: 10.1056/NEJMoa1006221.
5
Total hepatectomy, recombinant activated factor VII and rescue liver transplantation.全肝切除术、重组活化凝血因子 VII 和挽救性肝移植。
Minerva Anestesiol. 2010 Jul;76(7):550-3.
6
Recombinant activated factor VII as a general haemostatic agent: evidence-based efficacy and safety.重组活化凝血因子 VII 作为一种通用止血剂：基于证据的疗效与安全性
Curr Drug Saf. 2007 May;2(2):155-61. doi: 10.2174/157488607780598278.
7
Activated recombinant factor VII in orthotopic liver transplantation.
Transplant Proc. 2007 Jul-Aug;39(6):1883-5. doi: 10.1016/j.transproceed.2007.05.062.
8
Use of recombinant factor VIIa during orthotopic liver transplantation.重组凝血因子VIIa在原位肝移植中的应用。
Liver Transpl. 2006 Jul;12(7):1176-7; author reply 1178-9. doi: 10.1002/lt.20710.
9
Recombinant factor VIIa in major abdominal surgery and liver transplantation.重组凝血因子VIIa在腹部大手术及肝移植中的应用
Transplant Proc. 2006 Apr;38(3):818-9. doi: 10.1016/j.transproceed.2006.01.045.
10
Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores.重组凝血因子VIIa可降低终末期肝病模型（MELD）评分高的肝移植患者的输血需求。
Transfus Med. 2006 Apr;16(2):93-100. doi: 10.1111/j.1365-3148.2006.00653.x.
Zotero 插件